Inhibition of human adenoviruses by 1-(2′-hydroxy-5′-methoxybenzylidene)amino-3-hydroxyguanidine tosylate
- 31 August 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 24 (4), 261-273
- https://doi.org/10.1016/0166-3542(94)90074-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pretreatment with Topical 0.1% (S)-1 -(3-hydroxy-2-phosphonylmethoxypropyl)cytosine Inhibits Adenovirus Type 5 Replication in the New Zealand Rabbit Ocular ModelCornea, 1992
- Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitroAntiviral Research, 1991
- Design, synthesis, testing, and quantitative structure-activity relationship analysis of substituted salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate as new antiviral agents against coronavirusJournal of Medicinal Chemistry, 1990
- Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1987
- Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1985
- Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1985
- Adenovirus Infections in Patients Undergoing Bone-Marrow TransplantationNew England Journal of Medicine, 1985
- Novel N-hydroxyguanidine derivatives as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1984
- OUTBREAK OF INFANTILE GASTROENTERITIS DUE TO TYPE 40 ADENOVIRUSThe Lancet, 1983
- Gastroenteritis associated with enteric type adenovirus in hospitalized infantsThe Journal of Pediatrics, 1982